Lilly’s Amyvid receives European approval

Published



INDIANAPOLIS (AP) — European regulators approved the use of an imaging agent from Eli Lilly, which can help doctors diagnose Alzheimer’s disease.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.